📈 Economy
Hit
✦ AI
fxleaders.com reported July 24, 2026: 'September Hike Odds Jump to 80%' — triggered by Brent ~$100, rising US Treasury yields, elevated inflation expectations. Polymarket already shows 25% chance of July hike; if July holds (74–81%), September pressure rises sharply. Fed Chair Kevin Warsh is seen as inflation-sensitive hawk; Jackson Hole (Aug 27–29) will likely serve as signaling platform (see open prediction). Market-implied September hike probability: ~75–80% — applied here with slight discount: 73%.
💻 Technology
Hit
✦ AI
Palantir reports August 3, 2026 after market close (BusinessWire, July 13, 2026). Consensus ~$0.34 Non-GAAP EPS. Palantir has beaten consensus in each of the last six quarters, driven by booming US government contracts (DoD AIP, CIA analytics), strong commercial growth (~35% YoY), and direct benefit from elevated US defense spending amid geopolitical tensions. No direct Polymarket odds; historical beat probability ~66%.
💻 Technology
Hit
✦ AI
Cisco reported USD 1.3 billion in quarterly AI orders in its last quarter and raised its full-year AI revenue guidance to over USD 4 billion. The AI-driven Ethernet switching and optical transceiver boom benefits Cisco directly versus Nvidia Infiniband. Consensus EPS approx. USD 1.17 per share on expected revenue of USD 16.82 billion (TradingPedia, July 2026). No market quotes for Cisco Q4 FY2026 available.
🍾 Beverages
Miss
✦ AI
Diageo (Johnnie Walker, Guinness, Smirnoff, Baileys) cut its organic revenue outlook to minus 2 to minus 3% for the full year in the Q3 FY2026 trading update (May 2026). North America posted a high-single-digit organic decline in Q3. FY2025 had still shown +1.7% organic growth — the deterioration is sharp. Drivers: GLP-1 drug headwind on alcohol consumption, US destocking, and weak Shui Jing Fang segment in China. No market quotes available; forecast anchored directly on company guidance.
📈 Economy
Hit
✦ AI
AMD has beaten adjusted EPS consensus for eight consecutive quarters. The new Instinct MI450 AI GPU accelerators and Helios rack-scale AI system were unveiled at AMD Advancing AI 2026 (San Francisco, July 2026). The data centre segment benefits massively from the ongoing AI infrastructure boom. Consensus EPS approx. USD 1.60 (Barchart, July 2026). No Polymarket/Kalshi quotes for AMD Q2 2026 available; calibrated on the eight-quarter beat rate.
🏛️ Politics
Hit
✦ AI
Following the killing of Ayatollah Khamenei on 28 February 2026 by US/Israeli airstrikes, indirect nuclear negotiations via Qatari and Pakistani mediators have gained significant momentum. VP Vance stated on 1 July 2026: 'talks going well' (CNN). UN inspectors were granted temporary access to Iranian nuclear facilities. Key open issues: $300B reconstruction program, sanctions timeline, uranium enrichment level. Polymarket market 'Total Internet Blackout in Iran by August 31' active (proxy for domestic instability). No direct nuclear deal market found. Metaculus community estimates similar deal milestones for 2026 at ~25–35%. Own estimate 27% – advanced negotiations, but internal Iranian power consolidation after Khamenei's death and diverging demands slow formal agreement.
📈 Economy
Hit
✦ AI
Walmart reports Q2 FY2027 results (May–July 2026 period) on August 20, 2026 (pre-market). Analyst consensus: $0.75 EPS. Walmart's own Q2 guidance was $0.720–$0.740, so consensus already prices in a ~$0.01–$0.03 beat above guidance. Consumer backdrop was robust: UK Retail Sales June +1.0% MoM (ONS); US consumer spending stable. Walmart benefits structurally from Walmart+ subscriptions, Walmart Connect advertising, and resilient grocery. Risk: margin pressure from new Section 301 import tariffs (July 2026).
⚽ Sports
Miss
✦ AI
The 2026 Vuelta a España opens on August 22 with a 9.6km individual time trial through Monaco city streets (Casino Square). Remco Evenepoel (Soudal Quick-Step) is the reigning UCI TT World Champion and specialises in short, explosive urban ITTs. Primož Roglič (Red Bull–Bora–hansgrohe), forecast as GC winner in a separate open prediction, tends to save energy in opening time trials. Other contenders: Filippo Ganna (Ineos Grenadiers, if selected) and Stefan Küng (Groupama-FDJ). Aggregate odds imply ~30–35% for Evenepoel in an open field.
📈 Economy
Miss
✦ AI
Brent crude traded at $97.04 on July 24, 2026 — having briefly breached $100 driven by Middle East risk premia (Houthi Red Sea attacks, IDF–Hezbollah tensions) and new US tariffs. A return above $100 by late August is plausible if: (a) Middle East hostilities escalate, (b) OPEC+ refrains from production increases, (c) Houthi threat level is maintained. Counter-arguments: tariff-driven demand destruction and China slowdown. Net probability ~35%.
⚽ Sports
Miss
✦ AI
Aryna Sabalenka is the two-time defending champion (2024, 2025) and tops the 2026 US Open entry list. Bookmaker odds imply ~24% (odds +200), making her the clear favourite. Main rivals: Iga Swiatek (+550, ~15%), Elena Rybakina (+800, ~11%), Coco Gauff (+400, ~20%), Mirra Andreeva (+800, ~11%). Sabalenka's hard court record over the last 12 months: 31–4. Tournament runs August 23 – September 13, 2026. Cassandra adopts the market anchor of 24% without adjustment – Grand Slam title retention is statistically difficult (~35% for women's defending champions), but Sabalenka is clearly dominant on this surface.
📈 Economy
Hit
✦ AI
The PDUFA date for iberdomide (combination with daratumumab + dexamethasone, EXCALIBER-RRMM Phase 3 study) is August 17, 2026. BMS received both Breakthrough Therapy and Priority Review designation – both signals of strong regulatory support. The FDA historically approves ~83–87% of applications reaching a PDUFA date; with Breakthrough Therapy designation the rate is even higher (>90%). No negative Advisory Committee signal is known. Cassandra estimates the approval probability at 78% (slight discount vs historical average for a complex combination therapy).
💻 Technology
Miss
✦ AI
Anthropic filed its confidential S-1 on June 1, 2026 and selected Morgan Stanley, Goldman Sachs and JPMorgan Chase as lead underwriters on June 3, 2026. The most recent valuation (Series H, May 28, 2026) was $965bn post-money. A targeted IPO 'as early as October 2026' typically implies a public S-1 filing 4–6 weeks before roadshow start – i.e. September 2026. Key risks: market volatility from tech corrections, decision to remain private or delay to Q4. No direct Polymarket anchor; own estimate 43% (high preparation level but timing uncertainty remains).
🍾 Beverages
Hit
✦ AI
Molson Coors (Coors Light, Miller Lite, Blue Moon, Carling) reports Q2 2026 pre-market on August 6. EPS consensus is $1.52 (−25.9% YoY from $2.05). A lowered bar raises beat probability statistically: large beverage companies historically beat consensus ~65% of quarters. Coors Light and Miller Lite market-share gains in US on-premise channels since the 2023 Bud Light controversy provide ongoing tailwinds. Headwind: volume pressure from premium repositioning. No Polymarket/Kalshi market found; conservative calibration at 58%.